Treating surgical complications with the best quality care while minimizing costs remains a major challenge for hospitals. Especially when dealing with perioperative complications, hospitals have no unanimous standards for cost and care.
Treating surgical complications with the best quality care while minimizing costs remains a major challenge for hospitals. Especially when dealing with perioperative complications, hospitals have no unanimous standards for cost and care.
A new study in JAMA Surgery revealed a great amount of variation across hospitals in Medicare payments for patients rescued from surgical complications. Medicare payments for patients rescued at the highest-cost hospitals were 2- to 3-fold higher than the lowest-cost hospitals. Another revelation was that the hospitals with the highest costs for such care were also the ones where patients suffered the most complications in the first place.
Perioperative refers to the 3 phases of surgery: preoperative, intraoperative, and postoperative. Complications can arise in any of these 3 stages, leading to higher treatment costs and even death. The costs of rescuing patients from perioperative complications were poorly characterized until now.
Jason C. Pradarelli, MD, MS, and colleagues studied surgical Medicare patients across high-cost and low-cost hospitals to understand the differences in the cost of care. They analyzed Medicare claims of more than 576,000 people between ages 65 and 100. The payment components of the 4 most common operations from 2009 to 2012 were included: abdominal aortic aneurysm repair, colectomy for cancer, pulmonary surgery, and hip replacement. The average payments for patients who survived after surgical complications were compared across hospitals.
Higher Medicare Payments
In general, patients who survived the surgical complications faced higher Medicare payments than the patients who died for all 4 operation types. More specifically, Medicare payments for patients rescued at the highest-cost hospitals were 2- to 3-fold higher than the lowest-cost hospitals:
Moreover, these higher payments were not linked with improved clinical performance. In fact, the hospitals with the highest costs for such care were also the ones where patients suffered the most complications in the first place.
Rescue Comes at a Price
After a major surgery, problems can arise anytime, even weeks after the patient has left the operating table. These complications require intensive care in and beyond the hospital setting.
“We can see substantial variation in care, and cost, after a major complication occurs, even when we account for the type of complication and other factors,” Pradarelli, the lead author of the study, said in a statement. “This represents a real opportunity for hospitals to be more efficient in how they prevent and manage complications, for how Medicare incentivizes better care at lower costs.”
The vast variation in prices across hospitals to treat post-surgical complications presents a great opportunity for hospitals to improve cost efficiency.
“This study provides evidence for cost-efficiency while effectively treating patients with perioperative complications,” the authors wrote. “Emerging payment policies that incentivize high-quality care at lower costs may lead to previously unforeseen benefits even when applied to surgical patients who experience costly complications.”
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV
April 21st 2025Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Comparing Breast Cancer Treatment Outcomes Between Fee-for-Service and Medicare Advantage
April 4th 2025This study examined postdiagnosis breast cancer treatment outcomes for Medicare Advantage vs fee-for-service (FFS) Medicare in Ohio and found no significant differences overall but disparities for Black patients with FFS Medicare.
Read More